Investigating the role of interleukin-17-producing cells in the pathophysiology of canine immune mediated hemolytic anemia

05/13/2019
Breed(s): -All Dogs
Study Type: Blood Sample
Study Location: Ontario Veterinary College

Canine primary immune-mediated hemolytic anemia (IMHA) is an acute and severe disease of dogs, with a mortality rate ranging up to 70% in some studies. This study is examining a protein called interleukin-17 (IL-17), and the cells that produce this protein. IL-17 is found in increased amounts in people with certain disease processes, and could be involved in canine IMHA.

Participation Requirements:

Due to the need for fresh blood samples for this study, patient enrollment is limited to the Ontario Veterinary College. Participants in the study must be referred to the Ontario Veterinary College Health Sciences Centre by their primary veterinarian for care of newly diagnosed and untreated IMHA.

Owner's Responsibilities (Samples and Information to be collected):

Blood samples will be collected from dogs upon study enrollment. Whenever possible, this blood collection will be timed to occur during the same time that blood is being collected for recommended diagnostic tests.

Read more about AKC CHF grant #02515-A here!

 

Contact Information:

Name: Dr. Shauna Blois

Email: sblois@uoguelph.ca

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $50
  • $100
  • $250
  • $1000
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2018 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software